Tesofensine (NS2330)
NS2330 · monoamine reuptake inhibitor
An oral, non-peptide small molecule investigated for obesity after earlier neurologic development.
Mechanism
Inhibits norepinephrine, dopamine, and serotonin reuptake
Protocol studied in research
Study design shown in plain language. This is not a personal dosing recommendation.
Human evidence is absent, limited or not confirmatory
Anecdotal schedules are excluded because frequency of online repetition does not establish identity, safety, or a clinically meaningful dose.
Community-Reported Research Schedules
Descriptive community patterns are separated from clearly labeled trial-derived reference rows. Neither is personal dosing guidance.
| Research context or phase | Amount per administration | Schedule total | Frequency | Timing | Administration | Evidence level |
|---|---|---|---|---|---|---|
| Phase 2 oral reference | 0.25–1 mg | 0.25–1 mg/day | Once daily | Consistent daily time | Oral | Trial-derived reference |
Important: Repetition in online communities does not establish product identity, safety, effectiveness, or an appropriate exposure. Route-specific schedules, half-life estimates and reported cycle lengths are shown for comparison only.
Example Reconstitution Protocol
A hypothetical concentration calculation for literacy and review—not preparation, administration, or dosing instructions.
Tesofensine is an orally studied small molecule and does not use peptide-vial reconstitution.
Important: Vial strength, diluent identity, compatibility, sterility, stability and beyond-use time are product-specific. Never infer them from this arithmetic example. Use manufacturer, pharmacy, study, or licensed-clinician instructions for an actual preparation.
Cycle & Supplies Planning
Phase-by-phase cycle math showing how long a vial lasts and the estimated supplies required.
Tesofensine is an orally studied small molecule and does not use peptide-vial reconstitution.
Planning boundary: These are arithmetic examples based on the displayed research schedule—not personal dosing or purchasing instructions. Confirm product format, compatibility, route, sterility, storage, and discard timing independently. U-100 units measure liquid volume, not potency.
Safety signal
Heart rate, blood pressure, mood, sleep, and drug-interaction risks require clinical context.
Reported doses describe either a specific study or an unverified community pattern. Neither is personal medical guidance.